Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Pronorvistaon Nov 07, 2023 2:49pm
227 Views
Post# 35722081

ATE

ATEVolume start the US side too.

Q:ATBPF - ANTIBE THERAPEUTICS INC - Website unknown - click to update
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
ATBPF - Q not subscribed 0.7628 +0.11258 17.3 73.8 52 41 0.691  0.7628  0.69085 0.5865  0.281 14:09:32 Nov 01 15 min RT 2¢

 

Recent Trades - Last 10 of 41
Time ET Ex Price Change Volume
14:09:32 Q 0.7628 0.11258 6,550
14:08:16 Q 0.7628 0.11258 500
14:08:15 Q 0.7628 0.11258 1,000
14:08:15 Q 0.7628 0.11258 450
14:08:06 Q 0.76 0.10978 4,000
14:08:06 Q 0.76 0.10978 1,500
14:08:06 Q 0.76 0.10978 2,000
14:08:05 Q 0.76 0.10978 4,000
13:58:03 Q 0.751 0.10078 2,000
13:51:49 Q 0.751 0.10078 4,000

<< Previous
Bullboard Posts
Next >>